This report provides an overview of various clinical trial descriptors captured in the Pharma Intelligence Center until September 3, 2023.
Scope
- This report provides a review of different clinical trial designs derived from the Clinical Trials Database. The aim of this report is to provide analyses of these trials and assessment of trends in the data.
Reasons to Buy
- Understand the global clinical trial landscape for different trial descriptors.
- Identify key analysis of main features within several different trial descriptors.
Table of Contents
- Tables and Figures
- Executive Summary
- Introduction
- Examining Trial Descriptors
- Key Findings
- Appendix
Table 1: Count of Clinical Trial Designs
List of Figures
Figure 1 & 2: Number of FIH clinical trials, by phase and trial start year
Figure 3: Number of FIH clinical trials, by therapy area
Figure 4: Number of FIH clinical trials, by geography
Figure 5 & 6: Number of FIH clinical trials, by sponsor
Figure 7 & 8: Number of adaptive design clinical trials, by phase and trial start year
Figure 9: Number of adaptive design clinical trials, by therapy area
Figure 10: Number of adaptive design clinical trials, by geography
Figure 11 & 12: Number of adaptive design clinical trials, by sponsor
Figure 13 & 14: Number of pivotal/registration & post marketing commitment clinical trials, by year and sponsor type
Figure 15 & 16: Number of pivotal/registration & post marketing commitment clinical trials, by therapy area
Figure 17: Number of pivotal/registration clinical trials, by geography
Figure 18: Number of approved drugs with post marketing commitments clinical trials
Figure 19 & 20: Number of pivotal/registration clinical trials, by sponsor
Figure 21 & 22: Number of post marketing commitment clinical trials, by sponsor
Figure 23 & 24: Number of basket/bucket clinical trials, by phase and trial start year
Figure 25 & 26: Number of basket/bucket clinical trials, by therapy area and indication
Figure 27: Number of basket/bucket clinical trials, by geography
Figure 28 & 29: Number of basket/bucket clinical trials, by sponsor
Figure 30 & 31: Number of umbrella clinical trials, by phase and trial start year
Figure 32 & 33: Number of umbrella clinical trials, by therapy area and indication
Figure 35 & 36: Number of umbrella clinical trials, by sponsor
